Fox Run Management L.L.C. Purchases Shares of 25,181 Doximity, Inc. $DOCS

Key Points

• Fox Run Management L.L.C. has made a new investment in Doximity, purchasing 25,181 shares valued at approximately $1.46 million.
• Insider trading shows significant sales, with Director Regina M. Benjamin and Timothy S. Cabral selling 5,000 and 10,000 shares respectively, resulting in a decrease of their ownership stakes.
• Analyst ratings on Doximity are mixed, with target prices varying from $50 to $87, and an average rating of "Moderate Buy."

Fox Run Management L.L.C. acquired a new position in Doximity, Inc. (NASDAQ:DOCS - Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 25,181 shares of the company's stock, valued at approximately $1,461,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its stake in Doximity by 8.8% during the 1st quarter. Vanguard Group Inc. now owns 12,194,492 shares of the company's stock worth $707,646,000 after acquiring an additional 990,923 shares during the last quarter. Invesco Ltd. boosted its position in shares of Doximity by 54.8% during the first quarter. Invesco Ltd. now owns 1,969,326 shares of the company's stock worth $114,280,000 after buying an additional 696,923 shares during the period. Fuller & Thaler Asset Management Inc. boosted its position in shares of Doximity by 8.5% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 1,579,708 shares of the company's stock worth $84,341,000 after buying an additional 124,216 shares during the period. Dimensional Fund Advisors LP boosted its position in shares of Doximity by 4.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,576,455 shares of the company's stock worth $84,167,000 after buying an additional 63,815 shares during the period. Finally, Northern Trust Corp boosted its position in shares of Doximity by 9.4% during the fourth quarter. Northern Trust Corp now owns 1,459,185 shares of the company's stock worth $77,906,000 after buying an additional 125,332 shares during the period. 87.19% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research firms recently issued reports on DOCS. Wells Fargo & Company upped their target price on Doximity from $55.00 to $62.00 and gave the stock an "equal weight" rating in a report on Monday, August 4th. Morgan Stanley lowered their target price on Doximity from $71.00 to $60.00 and set an "equal weight" rating on the stock in a research note on Thursday, April 24th. Mizuho lowered their target price on Doximity from $65.00 to $60.00 and set a "neutral" rating on the stock in a research note on Friday, May 16th. Needham & Company LLC increased their price target on Doximity from $67.00 to $75.00 and gave the stock a "buy" rating in a research report on Friday, August 8th. Finally, Raymond James Financial increased their price target on Doximity from $65.00 to $75.00 and gave the stock an "outperform" rating in a research report on Friday, August 8th. Two equities research analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and ten have assigned a Hold rating to the stock. According to MarketBeat, Doximity currently has a consensus rating of "Moderate Buy" and a consensus price target of $66.21.

Doximity Stock Performance

Shares of DOCS stock traded down $2.6190 during mid-day trading on Tuesday, hitting $63.3110. The company's stock had a trading volume of 360,695 shares, compared to its average volume of 2,333,466. The company's fifty day simple moving average is $60.18 and its 200-day simple moving average is $60.32. Doximity, Inc. has a 52 week low of $35.32 and a 52 week high of $85.21. The company has a market cap of $11.86 billion, a PE ratio of 63.31, a P/E/G ratio of 4.10 and a beta of 1.36.

Doximity (NASDAQ:DOCS - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The company reported $0.36 earnings per share for the quarter, topping the consensus estimate of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%.During the same period last year, the firm posted $0.28 earnings per share. The business's quarterly revenue was up 15.2% on a year-over-year basis. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. On average, equities analysts anticipate that Doximity, Inc. will post 0.99 earnings per share for the current year.

Insider Activity at Doximity

In other Doximity news, Director Timothy S. Cabral sold 10,000 shares of Doximity stock in a transaction dated Wednesday, June 25th. The stock was sold at an average price of $60.00, for a total transaction of $600,000.00. Following the completion of the transaction, the director owned 6,360 shares in the company, valued at approximately $381,600. The trade was a 61.12% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Regina M. Benjamin sold 5,000 shares of Doximity stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $63.00, for a total value of $315,000.00. Following the transaction, the director owned 16,618 shares of the company's stock, valued at $1,046,934. This trade represents a 23.13% decrease in their position. The disclosure for this sale can be found here. Insiders sold 36,000 shares of company stock valued at $2,140,940 in the last three months. Corporate insiders own 31.30% of the company's stock.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.